ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3089

Evaluation of Learned Helplessness, Perceived Self-Efficacy and Functional Capacity in Patients with Fibromyalgia and Rheumatoid Arthritis

Sebastian Moyano1, Marina Scolnik1, Facundo Vergara1, Maria Victoria Garcia2, Mirtha Sabelli3, Javier Rosa4 and Enrique R. Soriano5, 1Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Buenos Aires, Argentina, 2Internal Services, Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Buenos Aires, Argentina, 3Cabrera 2964 Piso 6, Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Buenos Aires, Argentina, 4Rheumatology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 5Internal Medicine, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: fibromyalgia and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Fibromyalgia: Clinical Issues

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Chronic diseases involve cognitive and emotional aspects of patients. One relevant cognitive factor is the learned helplessness (LH), defined as an inadequate perception of the disease, generating feeling of defenselessness, behaviors of passivity, loss of self-esteem and belief that nothing you do can improve your situation. Another important cognitive factor is perceived self-efficacy (SE), which is defined as the individual’s abilities to cope with the disease. It has been reported that patients with higher LH, have more pain and functional disability. On the other hand, patients with high levels of SE have less pain, LH and functional disability. The relationship of these cognitive aspects has not been fully studied in fibromyalgia (FM). Our purpose was to evaluate LH and SE in patients with fibromyalgia and compared them with patients with rheumatoid arthritis (RA), and to assess their association with functional disability and level of perceived pain and fatigue in both groups of patients.

Methods: Consecutive patients, older than 18 years, with diagnosis of RA (2010 ACR/EULAR criteria) and with diagnosis of fibromyalgia (1990 or 2010 ACR criteria) seen at the outpatient rheumatology unit between March 2014 and June 2015, were included. During the inclusion visit the following data were collected: HAQ-A (Health Auto Questionnaire-simplified Argentinean validation); pain (VAS); fatigue (VAS); LH measured with Rheumatology Attitudes Index (RAI) and SE measured by Arthritis Self-auto-efficacy Scale. Descriptive statistics were calculated and compared between both groups. Correlations were calculated between LH and SE and pain, fatigue and HAQ-A, using Pearson tests. 

Results: One hundred and fifteen patients with RA and 57 patients with FM were included. Patient’s characteristics are shown in table 1. Patients with FM had significantly more pain, more fatigue, more LH, and less SE than RA patients (table 1). There was a significant positive correlation between LH, and pain (RA: r=0.67; p<0.001; FM: 0.59; p<0.001); HAQ-A (RA: r=0.65; p<0.001; FM: r=0.52; p= 0.0004), and fatigue (RA: r=0.54; p<0.001; FM: r=0.49; p= 0.0010); and a negative correlation between SE and pain (RA: r= – 0.47; p<0.001; FM; r= -0.59; p<0.001); HAQ-A (RA: r= -0.47; p<0.001; FM: r= -0.42; p= 0.0112) in both patient’s groups. 

Conclusion: Patients with FM had more LH, pain and fatigue than RA, and less SE. There was a significant correlation between these psychological assessments and pain, functional capacity and fatigue. LH and SE are potentially modifiable cognitive factors that correlated with functional disability and patients related outcomes. This might have clinical implications.

Table 1

Characteristics

RA (n=115)

FM (n=57)

P value

Female , n (%)

94 (82)

55 (96.5)

0.007

Age, years, mean (DS)

58 (13)

59 (14)

0.727

Time from diagnosis (years), mean (SD)

12 (10)

2 (2.8)

<0.0001

HAQ-A,  mean (DS)

0.75 (0.76)

0.73 (0.59)

0.832

Pain (VAS,0-100),  Mean (SD)

31 (28)

61 (25)

<0.0001

Fatigue (VAS, 0-100),  Mean (SD)

26 (28)

66 (26)

<0.0001

Learned helplessness,  Median (IQR)

10.4 (4.8)

14.5 (6.1)

<0.0001

Self-efficacy,  Mean (SD)

61 (15.4)

48 (18.6)

<0.0001


Disclosure: S. Moyano, None; M. Scolnik, None; F. Vergara, None; M. V. Garcia, None; M. Sabelli, None; J. Rosa, None; E. R. Soriano, Abbvie; Janssen; UCB; Roche; Bristol Myers Squibb, 2,Abbvie; UCB; Janssen; Roche; Bristol Myers Squibb; Pfizer; Novartis, 8.

To cite this abstract in AMA style:

Moyano S, Scolnik M, Vergara F, Garcia MV, Sabelli M, Rosa J, Soriano ER. Evaluation of Learned Helplessness, Perceived Self-Efficacy and Functional Capacity in Patients with Fibromyalgia and Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/evaluation-of-learned-helplessness-perceived-self-efficacy-and-functional-capacity-in-patients-with-fibromyalgia-and-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluation-of-learned-helplessness-perceived-self-efficacy-and-functional-capacity-in-patients-with-fibromyalgia-and-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology